Organon & Co (OGN)
18.07
-0.71
(-3.78%)
USD |
NYSE |
Nov 01, 16:00
18.02
-0.05
(-0.28%)
After-Hours: 20:00
Organon Price to Book Value: 9.440 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 9.440 |
| October 31, 2024 | 9.810 |
| October 30, 2024 | 9.366 |
| October 29, 2024 | 9.325 |
| October 28, 2024 | 9.121 |
| October 25, 2024 | 8.964 |
| October 24, 2024 | 8.996 |
| October 23, 2024 | 8.990 |
| October 22, 2024 | 9.064 |
| October 21, 2024 | 9.116 |
| October 18, 2024 | 9.199 |
| October 17, 2024 | 9.215 |
| October 16, 2024 | 9.372 |
| October 15, 2024 | 9.424 |
| October 14, 2024 | 9.455 |
| October 11, 2024 | 9.403 |
| October 10, 2024 | 9.393 |
| October 09, 2024 | 9.419 |
| October 08, 2024 | 9.455 |
| October 07, 2024 | 9.466 |
| October 04, 2024 | 9.554 |
| October 03, 2024 | 9.539 |
| October 02, 2024 | 9.706 |
| October 01, 2024 | 9.837 |
| September 30, 2024 | 9.993 |
| Date | Value |
|---|---|
| September 27, 2024 | 34.29 |
| September 26, 2024 | 34.28 |
| September 25, 2024 | 34.03 |
| September 24, 2024 | 35.15 |
| September 23, 2024 | 35.26 |
| September 20, 2024 | 34.85 |
| September 19, 2024 | 36.08 |
| September 18, 2024 | 35.71 |
| September 17, 2024 | 36.74 |
| September 16, 2024 | 37.33 |
| September 13, 2024 | 36.60 |
| September 12, 2024 | 36.28 |
| September 11, 2024 | 36.05 |
| September 10, 2024 | 35.92 |
| September 09, 2024 | 36.08 |
| September 06, 2024 | 36.64 |
| September 05, 2024 | 38.19 |
| September 04, 2024 | 39.73 |
| September 03, 2024 | 39.48 |
| August 30, 2024 | 39.96 |
| August 29, 2024 | 39.89 |
| August 28, 2024 | 40.18 |
| August 27, 2024 | 40.07 |
| August 26, 2024 | 41.18 |
| August 23, 2024 | 39.98 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.527
Minimum
Jun 09 2021
117.66
Maximum
May 22 2024
51.00
Average
37.19
Median
Aug 20 2024
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.59 |
| Biomarin Pharmaceutical Inc | 2.345 |
| Cassava Sciences Inc | 6.654 |
| Ligand Pharmaceuticals Inc | 2.593 |
| TG Therapeutics Inc | 23.45 |
Price to Book Value Related Metrics
| PE Ratio | 3.585 |
| PS Ratio | 0.7283 |
| PEG Ratio | 0.0299 |
| Price to Free Cash Flow | 7.226 |
| Price | 18.07 |
| Earnings Yield | 27.89% |
| Market Cap | 4.654B |
| PEGY Ratio | 0.0284 |
| Operating PE Ratio | 3.108 |
| Normalized PE Ratio | 3.207 |